Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Promising second generation vascular targeting agent

April 20, 2004

Gloucester Pharmaceuticals acquires license to FK-228

April 19, 2004

New phase I trial for VEGF Trap

April 19, 2004

CB-300945, a novel selective alpha-FR targeted thymidylate synthase inhibitor

April 19, 2004

Novacea provides evidence for the antitumor effects of DN-101 and AQ4N

April 19, 2004

Novel androgen receptor antagonist for advanced prostate cancer therapy designed by BMS

April 19, 2004

Small molecule inhibitor of hypoxia-inducible factor-1 identified

April 19, 2004

New phosphatase inhibitors active against hepatoma cells in vitro

April 19, 2004

Myriad Genetics licenses rights to new colon cancer gene MYH

April 16, 2004

SBIR grant supports Kosan's development of next-generation Hsp90 inhibitors

April 16, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...